These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis. Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030 [TBL] [Abstract][Full Text] [Related]
4. Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial. Atkinson MA; Juraschek SP; Bertenthal MS; Detrick B; Furth SL; Miller ER Pediatr Nephrol; 2017 May; 32(5):859-868. PubMed ID: 28013381 [TBL] [Abstract][Full Text] [Related]
5. The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease. Pistis KD; Westerberg PA; Qureshi AR; Beshara S; Sterner G; Bárány P; Linde T BMC Nephrol; 2023 Jan; 24(1):20. PubMed ID: 36698076 [TBL] [Abstract][Full Text] [Related]
6. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736 [TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease. Yadav AK; Kumar V; Banerjee D; Gupta KL; Jha V J Steroid Biochem Mol Biol; 2018 Jun; 180():15-18. PubMed ID: 29331722 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease. Yadav AK; Kumar V; Kumar V; Banerjee D; Gupta KL; Jha V J Bone Miner Res; 2018 Mar; 33(3):404-409. PubMed ID: 29044707 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D. Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750 [TBL] [Abstract][Full Text] [Related]
10. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD. Stubbs JR; Zhang S; Friedman PA; Nolin TD Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D supplementation for sickle cell disease. Soe HHK; Abas AB; Than NN; Ni H; Singh J; Said ARBM; Osunkwo I Cochrane Database Syst Rev; 2020 May; 5(5):CD010858. PubMed ID: 32462740 [TBL] [Abstract][Full Text] [Related]
12. Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial. Obi Y; Yamaguchi S; Hamano T; Sakaguchi Y; Shimomura A; Namba-Hamano T; Mikami S; Nishi O; Tanaka M; Kamoto A; Obi Y; Tomosugi N; Tsubakihara Y; Isaka Y Sci Rep; 2020 Sep; 10(1):15500. PubMed ID: 32968158 [TBL] [Abstract][Full Text] [Related]
13. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402 [TBL] [Abstract][Full Text] [Related]
14. High-Dose Vitamin D Smith EM; Jones JL; Han JE; Alvarez JA; Sloan JH; Konrad RJ; Zughaier SM; Martin GS; Ziegler TR; Tangpricha V JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):87-94. PubMed ID: 29505145 [TBL] [Abstract][Full Text] [Related]
15. High-dose vitamin D Smith EM; Alvarez JA; Kearns MD; Hao L; Sloan JH; Konrad RJ; Ziegler TR; Zughaier SM; Tangpricha V Clin Nutr; 2017 Aug; 36(4):980-985. PubMed ID: 27402475 [TBL] [Abstract][Full Text] [Related]
16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
17. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Wetmore JB; Kimber C; Mahnken JD; Stubbs JR Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190 [TBL] [Abstract][Full Text] [Related]
19. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial. de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120 [TBL] [Abstract][Full Text] [Related]
20. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]